Skip to content
Home/Companies/Healthcare/Envision Pharma

Envision Pharma

Healthcare·UK·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns Envision Pharma?

Envision Pharma was owned by Ardian through Ardian Buyout Fund VI (2016 vintage) from 2016 to 2021, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Ardian
Investor
Ardian
Ardian Buyout Fund VI · 2016 · Buyout

Key facts

HQUnited Kingdom
SectorHealthcare
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2021

More from Ardian Buyout Fund VI

Other portfolio companies in the same fund.

Solina
Solina
Exited 2021
ConsumerFrance· 2018
to
D & B audiotechnik
D & B audiotechnik
Exited 2023
TMTGermany· 2016
to
Dedalus
Dedalus
Active
HealthTechItaly· 2016
Kersia
Exited 2020
HealthcareFrance· 2016
to
Trigo
Trigo
Exited 2026
Business ServicesFrance· 2016
to
Weber Automotive
Weber Automotive
Exited 2019
IndustrialsGermany· 2016

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Envision Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Envision Pharma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Envision Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue